(Q73630418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

hepatocellular carcinoma

1 reference

resectable hepatocellular carcinoma

inferred from title

1 reference

G Y Chau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C W Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W Y Lui

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T J Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H L Kao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L H Wu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K L King

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C C Loong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Y Hsia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C W Chi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

552-558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

5 November 2019

cites work

1 reference

12 December 2020

Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter

1 reference

12 December 2020

IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines

1 reference

12 December 2020

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

12 December 2020

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

1 reference

12 December 2020

Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures

1 reference

12 December 2020

Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein

1 reference

12 December 2020

Biological and clinical aspects of interleukin 6.

1 reference

12 December 2020

Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer

1 reference

12 December 2020

Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry

1 reference

12 December 2020

Biological properties of interleukin 10

1 reference

12 December 2020

Interleukin-6 activity in urine and serum in patients with bladder carcinoma

1 reference

12 December 2020

Interleukin-6 in renal cell carcinoma

1 reference

12 December 2020

Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection

1 reference

12 December 2020

Acute-Phase Proteins and Interleukin 6 Serum Level in Head and Neck Cancer

1 reference

12 December 2020

Serum interleukin 10 in early stage multiple myeloma

1 reference

12 December 2020

Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?

1 reference

12 December 2020

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

12 December 2020

Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor

1 reference

12 December 2020

Interleukin-10 and cancer

1 reference

12 December 2020

Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

1 reference

12 December 2020

Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages

1 reference

12 December 2020

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

12 December 2020

Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10

1 reference

12 December 2020

Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma

1 reference

12 December 2020

Increased interleukin-10 serum levels in patients with solid tumours.

1 reference

12 December 2020

Serum interleukin-6 levels reflect disease status of gastric cancer

1 reference

12 December 2020

[Role of interleukin 6 in hepatocellular carcinoma]

1 reference

12 December 2020

Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa

1 reference

12 December 2020

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis

1 reference

12 December 2020

Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease

1 reference

12 December 2020

Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients

1 reference

12 December 2020

Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker

1 reference

12 December 2020

B cell growth and differentiation induced by supernatants of transformed epithelial cell lines

1 reference

12 December 2020

10.1097/00000658-200004000-00015

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10749617%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference